Close

CASI Pharma (CASI) Acquires HBV ANDA from Laurus Labs Limited

October 23, 2018 7:13 AM EDT Send to a Friend
CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to the development and delivery of high quality, cost-effective pharmaceutical ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login